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SUMMARY 
 
During the last few years our group has focus on assessing mammalian embryos 
viability in order to improve methods currently used in different assisted reproductive 
techniques: embryo transfer procedures, in vitro embryo production, cultivation, and 
cryopreservation techniques. Besides morphometric characterization of in vivo and in vitro 
produced embryos, after embryo recovery/fertilization and during the in vitro cultivation we 
also applied different intravital staining tests. Fluoresceine diacetate (FDA) is a non 
fluorescent analog of fluoresceine, which can easily penetrate the cell membrane of the living 
cells and under cellular esterase activity is hydrolyzed to fluoresceine, which emit green 
fluorescence while exposed to a fluorescence source of 494-518 nm wave length. The FDA 
metabolism depends on the esterase activity and at the same time on the plasmatic membrane 
integrity. Propidium iodide (Pi) poses the capacity to penetrate the cell membrane of the 
nonviable cells, binds inside the DNA molecules and show a red fluorescence while the cells 
are exposed to a fluorescence microscope at 515-560 nm (Lakowicz, 2006). 0.5 mg/ml FDA 
were used together with 0.1 mg/ml Pi to form a mixture that allows us to observe at the same 
time both living and death cells within the embryo. The embryos recovered at 48 hours after 
hCG administration, were evaluated by morphological and intravital staining tests. By 
morphological criteria 18% of the embryos were evaluated as poor and very poor quality 
while applying the FDA –Pi, 13.79% of the embryos were scored as no viable, differences 
being statistically significant. After quality scoring the embryos were cultivated for 72 hours 
in M16 culture media to study their future developmental capacity. After 24 hours of in vitro 
cultivation on M 16 media the differences between the proportions of embryos evolving to the 
morula stage were distinct significant (χ2 test, p≤0.01), 61.3% for the control group 
comparing to 38.7% of the FDA and Pi group. After 48 hours of cultivation, the percentage of 
embryos, which developed was more reduce compared to the retarded embryos (χ2test, 
p≤0.001), only for the control group embryos evolved to the hatched blastocyst stage 
(13.33%). For the FDA-Pi experimental group, embryos evolved in a small proportion to the 
expand blastocyst FDA and Pi (4.34%). Embryos developing up to blastocyst stage, indicates 
their ability to metabolize the staining dyes (Fluorescein diacetate), but the high percentage of 
retarded embryos shows a decreasing until stopping of developmental capacity after staining. 
Acknowledgments. This work was supported by CNCSIS-UEFISCSU, project number 
PNII-IDEI code2515/2008, contract number 1088/2009. 
REFERENCES 
1. Lakowicz, J.R. (2006). Principles of fluorescence Spectroscopy, 3rd edition, Springer 
Sciences. 
